Osiris Therapeutics Inc. will pay a $1.5 million fine to the U.S. Securities and Exchange Commission as part of a settlement over allegations that executives engaged in “wide-ranging fraud” to artificially inflate the company’s sales. Among the allegations, the SEC accuses former senior executives of Osiris of entering into undisclosed side agreements with distributors, recognizing revenue in direct contradiction to their disclosed accounting policies, lying to Osiris’ auditor, using false pricing…
from https://www.bizjournals.com/baltimore/news/2017/11/03/former-osiris-executives-face-criminal-charges-as.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/167092244372
No comments:
Post a Comment